Estée Lauder Companies
EL
$109.23
+0.39%
Estée Lauder is a global leader in prestige beauty, operating a portfolio of iconic brands — Estée Lauder, Clinique, M.A.C, La Mer, Jo Malone London, Aveda, Bobbi Brown and Origins — across skin care (49% of fiscal 2025 sales), makeup (29%), fragrance (17%) and hair care (5%), sold through department stores, travel retail, specialty beauty retailers, freestanding stores and e-commerce in more than 150 countries. Its competitive identity rests on brand equity and pricing power in the premium segment, with a geographic mix of roughly 31% Americas, 37% EMEA (heavily weighted to travel retail) and 32% Asia-Pacific, making it one of the most globally exposed names in the Household & Personal Products sector. The current investor narrative has shifted decisively toward a turnaround story: after a multi-year profit slump driven by weak Asia travel retail and inventory destocking, the company has posted accelerating sales and expanding margins, and the stock surged in August 2026 on evidence the restructuring is taking hold. Sentiment was further clarified in May 2026 when Estée Lauder walked away from merger talks with Spain's Puig, with investors rewarding the company for committing to an independent recovery plan rather than a dilutive combination. Debate now centers on whether margin recovery and a China/travel-retail rebound are durable enough to justify the re-rating already reflected in the share price.…
EL
Estée Lauder Companies
$109.23
Related headlines
Investment Opinion: Should I buy EL Today?
Rating: Hold. The synthesized recommendation is Hold, as the analyst consensus 'buy' rating and average target of $109.70 offer minimal upside (~1%) from the current price of $108.67, while the valuation is stretched and risks are elevated. The core thesis is that the turnaround is real but already priced in, leaving an unfavorable risk/reward for new money.\n\nSupporting Evidence: The stock trades at a trailing P/E of 157.9x and forward P/E of 27.6x, well above the sector average, while revenue growth of 6.33% YoY and gross margin of 75.46% show improvement but not enough to justify the multiple. Net margin is only 1.21%, and free cash flow of $1.316B TTM is positive but modest relative to the $28.6B market cap. The implied upside to the average target is just 0.9%, and the high target of $127 offers 16.9% upside, but the low target of $70 implies 35.6% downside.\n\nRisks & Conditions: The biggest risks are a China/travel retail slowdown, margin compression, and high leverage (D/E 2.43x). This Hold would upgrade to Buy if the stock pulls back to the $90-95 range (forward P/E ~22x) or if earnings accelerate beyond expectations (e.g., EPS exceeding $4.50). It would downgrade to Sell if revenue growth decelerates below 3% or if gross margin falls below 73%. Relative to its history and peers, the stock appears overvalued after the recent rally, and a period of consolidation is likely.
Sign up to view all
EL 12-Month Price Forecast
The 12-month outlook is balanced with a neutral stance. The company is showing tangible signs of a turnaround, but the stock has already rallied 35% in three months and trades at a premium valuation. The base case (50% probability) sees the stock trading around the analyst average target of $109.70, offering little upside. The bull case (25%) could drive the stock to $127 if growth accelerates, while the bear case (25%) could see a retest of $66-70 if the recovery falters. We would upgrade to bullish if revenue growth exceeds 7% and margins expand further, and downgrade to bearish if China/travel retail weakness persists or if earnings miss.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Estée Lauder Companies's 12-month outlook, with a consensus price target around $110.05 and implied upside of +0.8% versus the current price.
Average Target
$110.05
0 analysts
Implied Upside
+0.8%
vs. current price
Analyst Count
—
covering this stock
Price Range
$70 - $127
Analyst target range
Drowning in data?
Find the real signal!
Bulls vs Bears: EL Investment Factors
The bull case rests on tangible evidence of a turnaround: accelerating revenue growth (6.33% YoY), margin expansion (gross margin up 346 bps YoY), and a consensus buy rating with a $109.70 target. The bear case centers on extreme valuation (157.9x trailing P/E, 20.9x EV/EBITDA) and persistent unprofitability (net margin 1.21%, negative EPS in Q4). The most important tension is whether the margin recovery and China/travel-retail rebound are durable enough to justify the re-rating already reflected in the share price. Currently, the bull evidence is stronger on momentum and analyst sentiment, but the bear evidence is stronger on valuation and financial health. The stock's 35% 3-month rally suggests the market is betting on the bull case, but the thin margin of safety means any hiccup could trigger a sharp reversal.
Bullish
- Turnaround momentum accelerating: Revenue grew 6.33% YoY in Q4 2026 to $3.627B, with gross margin expanding to 75.46% from 72.00% a year earlier. Operating income swung to $254M from $141M, and EBITDA turned positive at $175M versus -$153M, signaling the restructuring is gaining traction.
- Margin recovery from trough: Gross margin has climbed from 72.0% in Q4 2025 to 75.46% in Q4 2026, while operating margin improved to 7.0% from 4.1%. The Q3 2026 operating margin of 15.0% shows the underlying earnings power when travel retail and Asia headwinds abate.
- Analyst consensus buy with upside: 28 analysts rate EL a 'buy' with a mean recommendation of 2.27 and an average target price of $109.70, implying ~1% upside from $108.67. The high target of $127 suggests 16.9% upside if the turnaround exceeds expectations.
- Strong relative strength vs. market: EL has outperformed the S&P 500 by 32.5 percentage points over 3 months and 33.2 points over 6 months, with a 35.3% 3-month return versus 2.85% for SPY. This momentum reflects growing investor confidence in the recovery story.
Bearish
- Extreme valuation multiples: EL trades at a trailing P/E of 157.9x and a forward P/E of 27.6x, with EV/EBITDA at 20.9x and P/B at 7.5x. These multiples price in a flawless recovery and leave little room for disappointment.
- Thin net margin and negative earnings: Net margin is just 1.21%, and Q4 2026 net income was -$116M (EPS -$0.32). The company remains unprofitable on a GAAP basis, with a negative PEG ratio of -1.36 reflecting the lack of positive earnings growth.
- High leverage and weak coverage: Debt-to-equity stands at 2.43x, with interest expense of $84M in Q4 2026. The current ratio of 1.22 is adequate but not strong, and the payout ratio of 279% indicates the dividend is not covered by earnings.
- Geographic concentration risk: 37% of revenue comes from EMEA (heavily travel retail) and 32% from Asia-Pacific, making EL vulnerable to Chinese consumer weakness and travel retail destocking. Any slowdown in these regions could derail the recovery.
EL Technical Analysis
Beta
1.26
1.26x market volatility
Max Drawdown
-43.8%
Largest decline past year
52-Week Range
$66-$122
Price range past year
Annual Return
+11.9%
Cumulative gain past year
| Period | EL Return | S&P 500 |
|---|---|---|
| 1m | +17.7% | -0.9% |
| 3m | +30.2% | +1.2% |
| 6m | +37.7% | +4.9% |
| 1y | +11.9% | +11.2% |
| ytd | +2.3% | +10.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
EL Fundamental Analysis
Quarterly Revenue
$3.6B
2026-06
Revenue YoY Growth
+6.3%
YoY Comparison
Gross Margin
75.5%
Latest Quarter
Free Cash Flow
$1.3B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is EL Overvalued?
PE
157.9x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 31x~169x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
20.9x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Estée Lauder carries a significant debt burden with a debt-to-equity ratio of 2.43x, and interest expense of $84M in Q4 2026 alone. The company's net margin is razor-thin at 1.21%, and it reported a net loss of $116M in Q4 2026 (EPS -$0.32), highlighting earnings volatility. The dividend payout ratio of 279% is unsustainable without a sharp earnings recovery, and free cash flow of $1.316B TTM provides some cushion but may be pressured if margins stall. Revenue concentration in skin care (49% of sales) and geographic exposure to EMEA travel retail (37% of revenue) add operational risk.\n\nMarket & Competitive Risks: EL trades at a trailing P/E of 157.9x and EV/EBITDA of 20.9x, leaving it vulnerable to valuation compression if growth expectations are not met. The beta of 1.265 indicates the stock is more volatile than the market, and with the S&P 500 up 13.13% over the past year while EL gained only 9.23%, there is relative underperformance risk. The prestige beauty segment is highly competitive, with rivals like L'Oréal and emerging indie brands challenging market share. Regulatory headwinds in China and travel retail dynamics could also pressure results. Recent news highlights the turnaround narrative, but any negative surprise could quickly reverse sentiment.\n\nWorst-Case Scenario: A worst-case scenario would involve a renewed slowdown in China and travel retail, coupled with margin compression and a failure to achieve the restructuring targets. This could lead to a re-rating to the 52-week low of $66.22, representing a 39.1% downside from the current price of $108.67. The analyst low target of $70 implies a 35.6% decline. Given the max drawdown of -43.79% over the past year, such a scenario is not implausible if earnings disappoint. Investors could lose over a third of their investment in this adverse case.
FAQ
The key risks include: 1) Financial risk: high debt-to-equity of 2.43x and a payout ratio of 279%, which could strain the balance sheet if earnings don't recover. 2) Operational risk: revenue concentration in skin care (49%) and geographic exposure to EMEA travel retail (37%) and Asia-Pacific (32%), making it vulnerable to regional downturns. 3) Valuation risk: the stock trades at a premium (157.9x trailing P/E), and any slowdown could trigger a sharp selloff. 4) Competitive risk: intense competition in prestige beauty could pressure market share and margins. These risks are ranked in order of severity, with financial and operational risks being the most immediate.
Our 12-month forecast has three scenarios: Bull (25% probability) with a target range of $120-127, Base (50%) at $100-115, and Bear (25%) at $66-70. The base case is most likely, assuming revenue growth of 5-6% and EPS around $4.23, which aligns with the analyst average target of $109.70. The bull case requires accelerating growth and margin expansion, while the bear case assumes a stall in the turnaround. The key assumption for the base case is that China and travel retail stabilize and margins hold above 75%.
EL appears overvalued on most metrics. The trailing P/E of 157.9x is extremely high, and the forward P/E of 27.6x is above the sector average, while the PEG ratio is negative due to lack of earnings growth. EV/EBITDA of 20.9x and P/B of 7.5x are also rich. The market is pricing in a strong recovery, with EPS expected to jump to $4.23 in FY2027 from near-zero. If the company delivers, the valuation could be justified, but any disappointment could lead to multiple compression. Compared to its own history, the stock is trading at a premium, and relative to peers like L'Oréal (forward P/E ~25x), it is slightly expensive.
EL is a good buy only for investors with a high risk tolerance and a long-term horizon, as the turnaround is still in its early stages. The stock trades at a forward P/E of 27.6x and offers just 1% upside to the average analyst target of $109.70, while the downside to the 52-week low of $66.22 is 39%. The consensus rating is 'buy,' but the risk/reward is skewed negatively after the recent 35% rally. A better entry point would be below $95, where the valuation is more attractive. For those who believe in the long-term brand strength and margin recovery, EL could be a worthy holding, but patience is required.
EL is more suitable for long-term investment (minimum 2-3 years) given the turnaround nature and volatility (beta 1.265). The stock has a dividend yield of 1.78%, but the payout ratio of 279% suggests the dividend may be at risk, so income is not a primary reason to hold. Earnings visibility is low in the near term, making short-term trading risky. A long-term horizon allows time for the restructuring to bear fruit and for the valuation to normalize. Short-term traders might capitalize on momentum, but the high valuation and recent rally increase the risk of a pullback.